CORC  > 武汉大学
The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis
Peng, Min; Li, Xing; Lei, Gu; Weng, Yi Ming; Hu, Meng Xue; Song, Qi Bin
刊名ONCOTARGETS AND THERAPY
2018
卷号11
关键词immune checkpoint inhibitor lung cancer combination therapy chemoradiotherapy meta-analysis
ISSN号1178-6930
DOI10.2147/OTT.S177318
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4156313
专题武汉大学
推荐引用方式
GB/T 7714
Peng, Min,Li, Xing,Lei, Gu,et al. The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis[J]. ONCOTARGETS AND THERAPY,2018,11.
APA Peng, Min,Li, Xing,Lei, Gu,Weng, Yi Ming,Hu, Meng Xue,&Song, Qi Bin.(2018).The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis.ONCOTARGETS AND THERAPY,11.
MLA Peng, Min,et al."The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis".ONCOTARGETS AND THERAPY 11(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace